SlideShare a Scribd company logo
GALL BLADDER CANCER
Dr. Zeeshan
OVERVIEW
 GB cancer is rare – traditionally incurable
 Late presentation
 Disseminated disease
 Dismal prognosis and lack of effective therapy
 Blalock – “ In malignancy of GB, when a diagnosis
can be made without exploration, no operation should
be performed, inasmuch as it only shortens the
patient’s life”
TENDENCY TO SPREAD
 Lymphatics
 Hematogenous
 Peritoneal
 Along biopsy tracts and wounds
 Overall 5 year survival : 5%
 Median survival : < 6 months
 Treatment : Complete surgical resection
EPIDEMIOLOGY
 Highest incidence:
- Females in India : (21.5 per 100,000)
- Females in Pakistan : (13.8 per 100,000)
 In USA : Females ( 2 per 100,000)
 Female : male – 3:1
 Increase in age : increase in incidence
 Obesity : BMI 30 – 34.9 vs 18.5 – 24.9 ---RR of
death from CA GB 2.13
ETIOLOGY
 Most consistent risk factor : Cholelithiasis with
chronic inflammation (75-90%)
 RR of CA GB with stone >3cm – 10.1
 Possibility of stone formation and CA sharing
same risk factors
 Stones may prompt a radiological workup /
cholecystectomy resulting in detection
CHRONIC INFLAMMATION
 Biliary enteric fistulas
 Typhoid infections
 Pancreaticobiliary malfunctions
 Calcification : PORCELAIN GB
- Type of calcification – degree of risk
Stippled >>>> Diffuse intramural calcification
CHEMICALS
 OCP
 Methyl Dopa
 INH
 Rubber industry
??ADENOMA- CARCINOMA
SEQUENCE
 Poor association
 No increased risk of malignancy in polyps
ANATOMY OF GALL BLADDER
 GB partially intraperitoneal structure – attached
to liver on segment IV b and V
 Side of GB attached to liver bed – no peritoneal
covering
 “Cystic plate” – fibrous lining
 In simple cholecystectomy – Plane between
muscularis of GB and cystic plate dissected
---INADEQUATE FOR CA GB
ANATOMY
 Body and fundus : Lies at a distance from major
inflow structures
Limited segmental resection (Segment IV b and
V) adequate
 Infundibulum : Encroaches onto the porta
hepatis
Tumors of this area – involves porta
Prepare to perform bile duct resection/ major
hepatic resection
LYMPHATICS
PATHOLOGY AND STAGING
 Fundus – 60% of tumors
 Body – 30% of tumors
 Neck – 10% of tumors
 Gross findings:
- Typical of chronic cholecystitis
- Tumors in lower end of GB obstructing –
HYDROPS
- Advanced tumors in neck/infundibulum –
jaundice / vascular invasion/ hepatic atrophy
GROSS DESCRIPTIONS
 Infiltrative
 Nodular
 Combined nodular infiltrative
 Papillary - Better prognosis
 Combined papillary infiltrative
PAPILLARY ADENOCARCINOMA
HISTOLOGY
 Adenocarcinoma – 89.4%
 Squamous / Adenosquamous – 4%
 Neuroendocrine – 3%
 Sarcoma/Adenosarcoma – 1.6%
 Melanoma - <1%
CLINICAL PRESENTATION
 SCENARIOS:
1. Final pathology after routine cholecystectomy
identifies CA GB
2. GB cancer discovered intraoperatively
3. GB cancer suspected before surgery
HISTORY
 Constant RUQ pain – rather than episodic
crampy pain of biliary colic
 Elderly patients
 Weight loss
 Anorexia
 Jaundice
COMMON SYMPTOMS AND SIGNS
LAB EXAMINATION (HELPFUL IN
ADVANCED DISEASE)
 Anemia
 Hypoalbuminemia
 Leukocytosis
 Elevated bilirubin
 Elevated Alkaline Phosphatase
 Tumor markers:
- CEA : 90% specific but lacks sensitivity (50%)
- CA19-9 : More consistent marker
Sensitivity : 75%
Specificity : 75%
RADIOLOGY
 USG : Excellent modality for GB
 Findings :
- Discontinuous mucosa
- Echogenic mucosa
- Submucosal echogenicity
 Doppler assessment of blood flow: Differentiates
malignant from benign
 Limitation : Unable to stage (Nodes cannot be
visualised)
CT/MRI
 Can assess extent of disease
 Detects presence of distant metastases
 MC finding : Mass in GB
 Assessment of LN:
- Size > 1cm
- Ring like heterogenous enhancement
CT/MRI
 CT : 71 – 84 % accurate
• 79% can differentiate between T1 and T2
• 93% between T2 and T3
• 100% between T3 and T4
 MRI:
- 70 – 100% sensitive for hepatic invasion
- 60 – 75% sensitive for LN spread
 FDG PET scan :
- More accurate than CT in diagnosing metastatic
disease
- Poor in differentiating benign inflammatory state
vs malignancy
PRE-OPERATIVE PATHOLOGICAL
DIAGNOSIS
 If CA-GB suspected on clinical and radiological
grounds – Histological diagnosis NOT necessary
 Biopsy increases risk of seeding
 If concern for GB malignancy significant –
Unwise to perform simple cholecystectomy
 For unresectable disease – Percutaneous needle
biopsy – 90% accurate
BILE CYTOLOGY
 Less risky way of making diagnosis without risk
of peritoneal seeding.
 Justifiable in patients undergoing ERCP/PTC
 If NOT - unwarranted
STAGING
SURGICAL MANAGEMENT
 Benign polyp :
- Adenomatous polyp – ONLY polypoidal lesion
with malignant potential
- Cholesterol polyp – MC polyp
 Indicators for cholecystectomy:
- Single polyp
- Size > 1 cm
- Age > 50 years
 Old concept – Offer OPEN cholecystectomy
 Current concept – Offer Laparoscopic
cholecystectomy + Frozen
 Diagnosis – USG required
 If polyp presents with abdominal pain – rule out
other causes
INCIDENTALLY DETECTED GB CA
 Incidence : 0.27 – 2.1%
 If diagnosis made by frozen – Prepare for
curative resection
 IF NOT COMFORTABLE – REFER
NO EFFECT ON OUTCOME
 T1a with margins negative : Standard
cholecystectom cures 85 – 100%
 T1b – controversial
 T2 onwards – plan liver resection
NON CURATIVE
CHOLECYSTECTOMY
 Careful work up required which includes :
- Reviewing pre-cholecystectomy USG to localise
extent
- Discuss case with operating surgeon
- Re-review T stage and margins pathologically
T1B LESIONS
 If cystic duct stump / margins +ve –
Bile duct resection and reconstruction
OR
Re-resection of cystic duct stump and frozen
proceed
EXTENT OF RESECTION BY STAGE
 Rational approach to CA GB depends on :
- Stage of disease
- Location of tumour
- Margins status – if cholecystectomy has already
been performed.
- Whether a prior noncurative cholecystectomy has
been performed
 T1a – Simple cholecystectomy
 T1b – Higher locoregional recurrence rates after
simple cholecystectomy
 T2,T3 – Complete enbloc resection with segment
Ivb and V of liver
 If invasion of hepatic inflow vascular structures
is documented :
- Extended right hepatectomy + LN clearance of
hepatoduodenal ligament + negative cystic
duct/bile duct margins
- Abandon major resection IF:
1. Nodal spread
2. Metastases
LIVER RESECTION
 Goal : To ensure a margin of 1-2 cm
 Anatomic resection – better than wedge resection
 If excision of segment IV b and V inadequate –
DO extended right hepatectomy:
 ESP in cases of large tumors invading portal
pedicle
 Tumors of lower end of GB encroaching onto
porta
 If isolated invasion of organ system present
EG: Stomach , duodenum, colon
In absence of distant metastases – DO local
resection
LYMPH NODAL DISSECTION
 Weigh risks vs benefits
 Range of operations include : Excision of cystic
duct node– Portal clearance–
pancreaticoduodencetomy
 1st
manouvre : Mobilisation of duodenum – To
assess aortocaval and retropancreatic nodes
 Assess celiac node LN – If suspicious DO frozen
and terminate procedure IF MALIGNANT
WHETHER ROUTINE BILE DUCT
RESECTION IS NECESSARY FOR
ADEQUATE LN CLEARANCE??
 Excising extrahepatic bile duct – makes LN
dissection easy
 Increases morbidity of operation
 No difference noted in the number of LN
harvested with OR without bile duct resection
 In general – bile duct resection NOT needed----
Unless suspicion of PORTA infiltration
 Stage of disease and NOT extent of resection
determines survival of patients
DID YOU KNOW?
 “Honeymoon and alcohol”
 Roots trace back to Babylon
 Tradition for the soon to be father- in-law to
supply his daughter’s fiance with a month of
mead
 Time period referred to as the HONEYMONTH
DID YOU KNOW?
 Adolf Hitler was one of the world’s best known abstainers from
alcohol.
Gall bladder cancer

More Related Content

What's hot

Liver tumours.pptx
Liver tumours.pptxLiver tumours.pptx
Liver tumours.pptx
Pradeep Pande
 
Pancreas Cancer
Pancreas CancerPancreas Cancer
Pancreas Cancer
Robert J Miller MD
 
Gall bladder cancer management
Gall bladder cancer managementGall bladder cancer management
Gall bladder cancer management
Romil Jain
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
SUNIL KUMAR PEDDANA
 
Carcinoma in gall bladder
Carcinoma in gall bladderCarcinoma in gall bladder
Carcinoma in gall bladder
NK
 
Ampullary carcinoma
Ampullary carcinomaAmpullary carcinoma
Ampullary carcinoma
Dr Tauqeer A Siddiqui MD FACP
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
Jyotindra Singh
 
Management of common bile duct stones
Management of common bile duct stonesManagement of common bile duct stones
Management of common bile duct stones
Arkaprovo Roy
 
Carcinoma stomach management
Carcinoma stomach   managementCarcinoma stomach   management
Carcinoma stomach management
Shriyans Jain
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
Dr KAMBLE
 
Gallblader carcinoma
Gallblader carcinomaGallblader carcinoma
Gallblader carcinoma
Anupshrestha27
 
Gall bladder carcinoma
Gall bladder carcinomaGall bladder carcinoma
Gall bladder carcinoma
Egyptian National Cancer Institute
 
Esophagus cancer
Esophagus cancerEsophagus cancer
Esophagus cancer
Robert J Miller MD
 
Gastric cancer presentation final
Gastric cancer presentation finalGastric cancer presentation final
Gastric cancer presentation finalTamer Madi
 
Stomach Cancer
Stomach CancerStomach Cancer
Stomach Cancer
Dr Neelesh Bhandari
 
Carcinoma oesophagus
Carcinoma oesophagusCarcinoma oesophagus
Carcinoma oesophagus
Dr Vandana Singh Kushwaha
 
Tumor small intestine
Tumor small intestineTumor small intestine
Tumor small intestine
kansal007
 
CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA
Shambhavi Sharma
 
Pancreatic Cancer.pptx
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
Kiran Ramakrishna
 
pancreatic cancer management
pancreatic cancer managementpancreatic cancer management
pancreatic cancer management
Nabeel Yahiya
 

What's hot (20)

Liver tumours.pptx
Liver tumours.pptxLiver tumours.pptx
Liver tumours.pptx
 
Pancreas Cancer
Pancreas CancerPancreas Cancer
Pancreas Cancer
 
Gall bladder cancer management
Gall bladder cancer managementGall bladder cancer management
Gall bladder cancer management
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
 
Carcinoma in gall bladder
Carcinoma in gall bladderCarcinoma in gall bladder
Carcinoma in gall bladder
 
Ampullary carcinoma
Ampullary carcinomaAmpullary carcinoma
Ampullary carcinoma
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
 
Management of common bile duct stones
Management of common bile duct stonesManagement of common bile duct stones
Management of common bile duct stones
 
Carcinoma stomach management
Carcinoma stomach   managementCarcinoma stomach   management
Carcinoma stomach management
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Gallblader carcinoma
Gallblader carcinomaGallblader carcinoma
Gallblader carcinoma
 
Gall bladder carcinoma
Gall bladder carcinomaGall bladder carcinoma
Gall bladder carcinoma
 
Esophagus cancer
Esophagus cancerEsophagus cancer
Esophagus cancer
 
Gastric cancer presentation final
Gastric cancer presentation finalGastric cancer presentation final
Gastric cancer presentation final
 
Stomach Cancer
Stomach CancerStomach Cancer
Stomach Cancer
 
Carcinoma oesophagus
Carcinoma oesophagusCarcinoma oesophagus
Carcinoma oesophagus
 
Tumor small intestine
Tumor small intestineTumor small intestine
Tumor small intestine
 
CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA
 
Pancreatic Cancer.pptx
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
 
pancreatic cancer management
pancreatic cancer managementpancreatic cancer management
pancreatic cancer management
 

Viewers also liked

Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
fitango
 
Diagnosis and Management of Bladder Cancer
Diagnosis and Management of Bladder CancerDiagnosis and Management of Bladder Cancer
Diagnosis and Management of Bladder Cancermeducationdotnet
 
Bladder cancer,tbl mcq
Bladder cancer,tbl  mcqBladder cancer,tbl  mcq
Bladder cancer,tbl mcqHabrol Afzam
 
03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m
Mohammed M. H. Hajhamad
 
Cancer of bladder
Cancer of bladderCancer of bladder
Cancer of bladder
AIIMS, Rishikesh
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
LAKSHMI DEEPTHI GEDELA
 
Bladder Cancer Diagnostic-Initial Team Project
Bladder Cancer Diagnostic-Initial Team ProjectBladder Cancer Diagnostic-Initial Team Project
Bladder Cancer Diagnostic-Initial Team Project
Sagar Desai
 
Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
shelbs531
 
Cancer of the Bladder
Cancer of the BladderCancer of the Bladder
Cancer of the Bladder
Robert J Miller MD
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
Amina Abdurahman
 
Hemopoiesis
HemopoiesisHemopoiesis
Bladder cancer
Bladder cancerBladder cancer

Viewers also liked (14)

Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
 
Diagnosis and Management of Bladder Cancer
Diagnosis and Management of Bladder CancerDiagnosis and Management of Bladder Cancer
Diagnosis and Management of Bladder Cancer
 
Bladder cancer,tbl mcq
Bladder cancer,tbl  mcqBladder cancer,tbl  mcq
Bladder cancer,tbl mcq
 
03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Cancer of bladder
Cancer of bladderCancer of bladder
Cancer of bladder
 
White Paper BC
White Paper BCWhite Paper BC
White Paper BC
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Bladder Cancer Diagnostic-Initial Team Project
Bladder Cancer Diagnostic-Initial Team ProjectBladder Cancer Diagnostic-Initial Team Project
Bladder Cancer Diagnostic-Initial Team Project
 
Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
 
Cancer of the Bladder
Cancer of the BladderCancer of the Bladder
Cancer of the Bladder
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Hemopoiesis
HemopoiesisHemopoiesis
Hemopoiesis
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 

Similar to Gall bladder cancer

Carcinoma Of gall Bladder.pptx
Carcinoma Of gall Bladder.pptxCarcinoma Of gall Bladder.pptx
Carcinoma Of gall Bladder.pptx
RahulMishra968735
 
Malignant obstructive jundice hegazy
Malignant obstructive jundice hegazyMalignant obstructive jundice hegazy
Malignant obstructive jundice hegazy
mostafa hegazy
 
Colon Cancer 9th Sem
Colon Cancer 9th SemColon Cancer 9th Sem
Colon Cancer 9th SemTanuj Bhatia
 
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptxcolorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
Gokul Krishnan
 
Colon cancer
Colon cancerColon cancer
Colon cancer
aa123123
 
gastriccancer-160627133725.pdf
gastriccancer-160627133725.pdfgastriccancer-160627133725.pdf
gastriccancer-160627133725.pdf
Khalidfadol
 
Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )
D.A.B.M
 
carcinomastomachpresentation-190929082053 (1).pdf
carcinomastomachpresentation-190929082053 (1).pdfcarcinomastomachpresentation-190929082053 (1).pdf
carcinomastomachpresentation-190929082053 (1).pdf
DRYOGESHMUNDRA2
 
Carcinoma stomach presentation
Carcinoma stomach presentationCarcinoma stomach presentation
Carcinoma stomach presentation
dayananda1210
 
Obstructivejaundice 130530070611-phpapp01 (1)
Obstructivejaundice 130530070611-phpapp01 (1)Obstructivejaundice 130530070611-phpapp01 (1)
Obstructivejaundice 130530070611-phpapp01 (1)
Mohammad Khalaily
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
Марко Ройс
 
Obstructive jaundice
Obstructive jaundiceObstructive jaundice
Obstructive jaundiceFazal Hussain
 
Carcinoma gallbladder
Carcinoma gallbladderCarcinoma gallbladder
Carcinoma gallbladder
Yugal Nepal
 
Pancreatic Cancer By Dr. Abdul Ghaffar
Pancreatic Cancer By Dr. Abdul GhaffarPancreatic Cancer By Dr. Abdul Ghaffar
Pancreatic Cancer By Dr. Abdul Ghaffar
Tabish Javed
 
carcinoma gall bladder
carcinoma gall bladdercarcinoma gall bladder
carcinoma gall bladder
DrAbrarAli
 
malignantobstructivejundicehegazy-191120103208.pptx
malignantobstructivejundicehegazy-191120103208.pptxmalignantobstructivejundicehegazy-191120103208.pptx
malignantobstructivejundicehegazy-191120103208.pptx
BedahULM
 
Ca stomach
Ca stomachCa stomach
Ca stomach
radiation oncology
 
carcinoma stomach
carcinoma stomachcarcinoma stomach
carcinoma stomach
DrYogeshMundra1
 
Management of asymptomatic gall stones and polyps final
Management of asymptomatic gall stones and polyps finalManagement of asymptomatic gall stones and polyps final
Management of asymptomatic gall stones and polyps final
AnupamLahiri2
 

Similar to Gall bladder cancer (20)

Carcinoma Of gall Bladder.pptx
Carcinoma Of gall Bladder.pptxCarcinoma Of gall Bladder.pptx
Carcinoma Of gall Bladder.pptx
 
Malignant obstructive jundice hegazy
Malignant obstructive jundice hegazyMalignant obstructive jundice hegazy
Malignant obstructive jundice hegazy
 
Colon Cancer 9th Sem
Colon Cancer 9th SemColon Cancer 9th Sem
Colon Cancer 9th Sem
 
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptxcolorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
 
Colon cancer
Colon cancerColon cancer
Colon cancer
 
gastriccancer-160627133725.pdf
gastriccancer-160627133725.pdfgastriccancer-160627133725.pdf
gastriccancer-160627133725.pdf
 
Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )
 
carcinomastomachpresentation-190929082053 (1).pdf
carcinomastomachpresentation-190929082053 (1).pdfcarcinomastomachpresentation-190929082053 (1).pdf
carcinomastomachpresentation-190929082053 (1).pdf
 
Carcinoma stomach presentation
Carcinoma stomach presentationCarcinoma stomach presentation
Carcinoma stomach presentation
 
Obstructivejaundice 130530070611-phpapp01 (1)
Obstructivejaundice 130530070611-phpapp01 (1)Obstructivejaundice 130530070611-phpapp01 (1)
Obstructivejaundice 130530070611-phpapp01 (1)
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
Obstructive jaundice
Obstructive jaundiceObstructive jaundice
Obstructive jaundice
 
Carcinoma gallbladder
Carcinoma gallbladderCarcinoma gallbladder
Carcinoma gallbladder
 
Pancreatic Cancer By Dr. Abdul Ghaffar
Pancreatic Cancer By Dr. Abdul GhaffarPancreatic Cancer By Dr. Abdul Ghaffar
Pancreatic Cancer By Dr. Abdul Ghaffar
 
carcinoma gall bladder
carcinoma gall bladdercarcinoma gall bladder
carcinoma gall bladder
 
malignantobstructivejundicehegazy-191120103208.pptx
malignantobstructivejundicehegazy-191120103208.pptxmalignantobstructivejundicehegazy-191120103208.pptx
malignantobstructivejundicehegazy-191120103208.pptx
 
Ca stomach
Ca stomachCa stomach
Ca stomach
 
carcinoma stomach
carcinoma stomachcarcinoma stomach
carcinoma stomach
 
Management of asymptomatic gall stones and polyps final
Management of asymptomatic gall stones and polyps finalManagement of asymptomatic gall stones and polyps final
Management of asymptomatic gall stones and polyps final
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 

More from zeeshanrahman86

Pilonidal sinus
Pilonidal sinusPilonidal sinus
Pilonidal sinus
zeeshanrahman86
 
Prevention and management of complications of pancreatic surgery
Prevention and management of complications of pancreatic surgeryPrevention and management of complications of pancreatic surgery
Prevention and management of complications of pancreatic surgery
zeeshanrahman86
 
Post cholecystectomy complications
Post  cholecystectomy complicationsPost  cholecystectomy complications
Post cholecystectomy complications
zeeshanrahman86
 
Conservative management of perforated peptic ulcers
Conservative management of perforated peptic ulcersConservative management of perforated peptic ulcers
Conservative management of perforated peptic ulcers
zeeshanrahman86
 
Surgical anatomy of inguinal hernia
Surgical anatomy of inguinal herniaSurgical anatomy of inguinal hernia
Surgical anatomy of inguinal hernia
zeeshanrahman86
 
Management of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic strictureManagement of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic stricture
zeeshanrahman86
 
Fibrovascular polyp
Fibrovascular polypFibrovascular polyp
Fibrovascular polyp
zeeshanrahman86
 
Approach to mediastinal mass
Approach to mediastinal massApproach to mediastinal mass
Approach to mediastinal mass
zeeshanrahman86
 
Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
zeeshanrahman86
 
Thyroid malignancy
Thyroid malignancyThyroid malignancy
Thyroid malignancy
zeeshanrahman86
 

More from zeeshanrahman86 (11)

Pilonidal sinus
Pilonidal sinusPilonidal sinus
Pilonidal sinus
 
Prevention and management of complications of pancreatic surgery
Prevention and management of complications of pancreatic surgeryPrevention and management of complications of pancreatic surgery
Prevention and management of complications of pancreatic surgery
 
Post cholecystectomy complications
Post  cholecystectomy complicationsPost  cholecystectomy complications
Post cholecystectomy complications
 
Conservative management of perforated peptic ulcers
Conservative management of perforated peptic ulcersConservative management of perforated peptic ulcers
Conservative management of perforated peptic ulcers
 
Surgical anatomy of inguinal hernia
Surgical anatomy of inguinal herniaSurgical anatomy of inguinal hernia
Surgical anatomy of inguinal hernia
 
Management of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic strictureManagement of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic stricture
 
Fibrovascular polyp
Fibrovascular polypFibrovascular polyp
Fibrovascular polyp
 
Approach to mediastinal mass
Approach to mediastinal massApproach to mediastinal mass
Approach to mediastinal mass
 
Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
 
Thyroid malignancy
Thyroid malignancyThyroid malignancy
Thyroid malignancy
 
Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 

Gall bladder cancer

  • 2. OVERVIEW  GB cancer is rare – traditionally incurable  Late presentation  Disseminated disease  Dismal prognosis and lack of effective therapy  Blalock – “ In malignancy of GB, when a diagnosis can be made without exploration, no operation should be performed, inasmuch as it only shortens the patient’s life”
  • 3. TENDENCY TO SPREAD  Lymphatics  Hematogenous  Peritoneal  Along biopsy tracts and wounds  Overall 5 year survival : 5%  Median survival : < 6 months  Treatment : Complete surgical resection
  • 4. EPIDEMIOLOGY  Highest incidence: - Females in India : (21.5 per 100,000) - Females in Pakistan : (13.8 per 100,000)  In USA : Females ( 2 per 100,000)  Female : male – 3:1  Increase in age : increase in incidence  Obesity : BMI 30 – 34.9 vs 18.5 – 24.9 ---RR of death from CA GB 2.13
  • 5. ETIOLOGY  Most consistent risk factor : Cholelithiasis with chronic inflammation (75-90%)  RR of CA GB with stone >3cm – 10.1  Possibility of stone formation and CA sharing same risk factors  Stones may prompt a radiological workup / cholecystectomy resulting in detection
  • 6.
  • 7. CHRONIC INFLAMMATION  Biliary enteric fistulas  Typhoid infections  Pancreaticobiliary malfunctions  Calcification : PORCELAIN GB - Type of calcification – degree of risk Stippled >>>> Diffuse intramural calcification
  • 8.
  • 9. CHEMICALS  OCP  Methyl Dopa  INH  Rubber industry
  • 10. ??ADENOMA- CARCINOMA SEQUENCE  Poor association  No increased risk of malignancy in polyps
  • 11. ANATOMY OF GALL BLADDER  GB partially intraperitoneal structure – attached to liver on segment IV b and V  Side of GB attached to liver bed – no peritoneal covering  “Cystic plate” – fibrous lining  In simple cholecystectomy – Plane between muscularis of GB and cystic plate dissected ---INADEQUATE FOR CA GB
  • 12.
  • 13. ANATOMY  Body and fundus : Lies at a distance from major inflow structures Limited segmental resection (Segment IV b and V) adequate  Infundibulum : Encroaches onto the porta hepatis Tumors of this area – involves porta Prepare to perform bile duct resection/ major hepatic resection
  • 15. PATHOLOGY AND STAGING  Fundus – 60% of tumors  Body – 30% of tumors  Neck – 10% of tumors  Gross findings: - Typical of chronic cholecystitis - Tumors in lower end of GB obstructing – HYDROPS - Advanced tumors in neck/infundibulum – jaundice / vascular invasion/ hepatic atrophy
  • 16. GROSS DESCRIPTIONS  Infiltrative  Nodular  Combined nodular infiltrative  Papillary - Better prognosis  Combined papillary infiltrative
  • 18. HISTOLOGY  Adenocarcinoma – 89.4%  Squamous / Adenosquamous – 4%  Neuroendocrine – 3%  Sarcoma/Adenosarcoma – 1.6%  Melanoma - <1%
  • 19. CLINICAL PRESENTATION  SCENARIOS: 1. Final pathology after routine cholecystectomy identifies CA GB 2. GB cancer discovered intraoperatively 3. GB cancer suspected before surgery
  • 20. HISTORY  Constant RUQ pain – rather than episodic crampy pain of biliary colic  Elderly patients  Weight loss  Anorexia  Jaundice
  • 22. LAB EXAMINATION (HELPFUL IN ADVANCED DISEASE)  Anemia  Hypoalbuminemia  Leukocytosis  Elevated bilirubin  Elevated Alkaline Phosphatase  Tumor markers: - CEA : 90% specific but lacks sensitivity (50%) - CA19-9 : More consistent marker Sensitivity : 75% Specificity : 75%
  • 23. RADIOLOGY  USG : Excellent modality for GB  Findings : - Discontinuous mucosa - Echogenic mucosa - Submucosal echogenicity  Doppler assessment of blood flow: Differentiates malignant from benign  Limitation : Unable to stage (Nodes cannot be visualised)
  • 24. CT/MRI  Can assess extent of disease  Detects presence of distant metastases  MC finding : Mass in GB  Assessment of LN: - Size > 1cm - Ring like heterogenous enhancement
  • 25.
  • 26. CT/MRI  CT : 71 – 84 % accurate • 79% can differentiate between T1 and T2 • 93% between T2 and T3 • 100% between T3 and T4  MRI: - 70 – 100% sensitive for hepatic invasion - 60 – 75% sensitive for LN spread
  • 27.  FDG PET scan : - More accurate than CT in diagnosing metastatic disease - Poor in differentiating benign inflammatory state vs malignancy
  • 28.
  • 29. PRE-OPERATIVE PATHOLOGICAL DIAGNOSIS  If CA-GB suspected on clinical and radiological grounds – Histological diagnosis NOT necessary  Biopsy increases risk of seeding  If concern for GB malignancy significant – Unwise to perform simple cholecystectomy  For unresectable disease – Percutaneous needle biopsy – 90% accurate
  • 30. BILE CYTOLOGY  Less risky way of making diagnosis without risk of peritoneal seeding.  Justifiable in patients undergoing ERCP/PTC  If NOT - unwarranted
  • 31.
  • 33.
  • 34. SURGICAL MANAGEMENT  Benign polyp : - Adenomatous polyp – ONLY polypoidal lesion with malignant potential - Cholesterol polyp – MC polyp  Indicators for cholecystectomy: - Single polyp - Size > 1 cm - Age > 50 years
  • 35.  Old concept – Offer OPEN cholecystectomy  Current concept – Offer Laparoscopic cholecystectomy + Frozen  Diagnosis – USG required  If polyp presents with abdominal pain – rule out other causes
  • 36. INCIDENTALLY DETECTED GB CA  Incidence : 0.27 – 2.1%  If diagnosis made by frozen – Prepare for curative resection  IF NOT COMFORTABLE – REFER NO EFFECT ON OUTCOME
  • 37.  T1a with margins negative : Standard cholecystectom cures 85 – 100%  T1b – controversial  T2 onwards – plan liver resection
  • 38. NON CURATIVE CHOLECYSTECTOMY  Careful work up required which includes : - Reviewing pre-cholecystectomy USG to localise extent - Discuss case with operating surgeon - Re-review T stage and margins pathologically
  • 39. T1B LESIONS  If cystic duct stump / margins +ve – Bile duct resection and reconstruction OR Re-resection of cystic duct stump and frozen proceed
  • 40. EXTENT OF RESECTION BY STAGE  Rational approach to CA GB depends on : - Stage of disease - Location of tumour - Margins status – if cholecystectomy has already been performed. - Whether a prior noncurative cholecystectomy has been performed
  • 41.  T1a – Simple cholecystectomy  T1b – Higher locoregional recurrence rates after simple cholecystectomy  T2,T3 – Complete enbloc resection with segment Ivb and V of liver
  • 42.  If invasion of hepatic inflow vascular structures is documented : - Extended right hepatectomy + LN clearance of hepatoduodenal ligament + negative cystic duct/bile duct margins - Abandon major resection IF: 1. Nodal spread 2. Metastases
  • 43. LIVER RESECTION  Goal : To ensure a margin of 1-2 cm  Anatomic resection – better than wedge resection  If excision of segment IV b and V inadequate – DO extended right hepatectomy:  ESP in cases of large tumors invading portal pedicle  Tumors of lower end of GB encroaching onto porta
  • 44.  If isolated invasion of organ system present EG: Stomach , duodenum, colon In absence of distant metastases – DO local resection
  • 45. LYMPH NODAL DISSECTION  Weigh risks vs benefits  Range of operations include : Excision of cystic duct node– Portal clearance– pancreaticoduodencetomy  1st manouvre : Mobilisation of duodenum – To assess aortocaval and retropancreatic nodes  Assess celiac node LN – If suspicious DO frozen and terminate procedure IF MALIGNANT
  • 46. WHETHER ROUTINE BILE DUCT RESECTION IS NECESSARY FOR ADEQUATE LN CLEARANCE??  Excising extrahepatic bile duct – makes LN dissection easy  Increases morbidity of operation  No difference noted in the number of LN harvested with OR without bile duct resection  In general – bile duct resection NOT needed---- Unless suspicion of PORTA infiltration
  • 47.  Stage of disease and NOT extent of resection determines survival of patients
  • 48.
  • 49. DID YOU KNOW?  “Honeymoon and alcohol”  Roots trace back to Babylon  Tradition for the soon to be father- in-law to supply his daughter’s fiance with a month of mead  Time period referred to as the HONEYMONTH
  • 50.
  • 51. DID YOU KNOW?  Adolf Hitler was one of the world’s best known abstainers from alcohol.